非瓣膜病心房颤动住院患者抗凝治疗现状及影响因素分析

Abstract

目的探讨非瓣膜病心房颤动住院患者抗凝治疗情况,并分析其临床影响因素。方法方便选取该院2010年9月—2013年10月期间收治的230例非瓣膜病心房颤动住院患者,依据2006年ACC/AHA/ESC房颤抗凝管理指南分为低危组、中危组以及高危组,分析其抗凝应用情况。结果房颤患者共221例,未根据指南抗凝的患者有174例,根据指南抗凝的患者有47例。结论当前该院基层医院住院的非瓣膜病心房颤动住院患者中,多数未接受指南推荐的抗凝剂治疗,尤其对于房颤脑卒中高危患者,更需要临床指南推荐。

Objective To discuss the status of anticoagulant therapy for inpatients with nonvalvuiar atrial fibrillation and analyze its clinical influence factors. Methods 230 cases of inpatients with nonvalvuiar atrial fibrillation admitted and treated in our hospital from September 2010 to October 2013 were selected and divided into the low-risk group, average-risk group and high-risk group according to the ACC/AHA/ESC atrial fibrillation anticoagulation manage guide in 2006, and the application conditions were analyzed. Results In the 221 cases of patients with atrial fibrillation, 174 cases of patients were not according to the guide for anticoagulation and 47 cases were according to the guide for anticoagulation. Conclusion At present, most of the patients with nonvalvuiar atrial fibrillation hospitalized in the primary hospital have not accepted the anticoagulant therapy recommended by guide, and especially for the?high-risk atrial fibrillation stroke patients, the clinical guide recommendation is more needed.